RVXCF
Price
$0.07
Change
+$0.01 (+16.67%)
Updated
Aug 8 closing price
Capitalization
22.73M
TELIF
Price
$0.27
Change
-$0.00 (-0.00%)
Updated
Aug 11 closing price
Capitalization
14.83M
Interact to see
Advertisement

RVXCF vs TELIF

Header iconRVXCF vs TELIF Comparison
Open Charts RVXCF vs TELIFBanner chart's image
Resverlogix
Price$0.07
Change+$0.01 (+16.67%)
Volume$4K
Capitalization22.73M
TELESCOPE INNOVATIONS
Price$0.27
Change-$0.00 (-0.00%)
Volume$15.09K
Capitalization14.83M
RVXCF vs TELIF Comparison Chart in %
Loading...
RVXCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RVXCF vs. TELIF commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVXCF is a Hold and TELIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (RVXCF: $0.07 vs. TELIF: $0.27)
Brand notoriety: RVXCF and TELIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RVXCF: 10% vs. TELIF: 181%
Market capitalization -- RVXCF: $22.73M vs. TELIF: $14.83M
RVXCF [@Biotechnology] is valued at $22.73M. TELIF’s [@Biotechnology] market capitalization is $14.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.01B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RVXCF’s FA Score shows that 1 FA rating(s) are green whileTELIF’s FA Score has 0 green FA rating(s).

  • RVXCF’s FA Score: 1 green, 4 red.
  • TELIF’s FA Score: 0 green, 5 red.
According to our system of comparison, both RVXCF and TELIF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVXCF’s TA Score shows that 4 TA indicator(s) are bullish while TELIF’s TA Score has 2 bullish TA indicator(s).

  • RVXCF’s TA Score: 4 bullish, 5 bearish.
  • TELIF’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, RVXCF is a better buy in the short-term than TELIF.

Price Growth

RVXCF (@Biotechnology) experienced а +12.73% price change this week, while TELIF (@Biotechnology) price change was +10.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVXCF($22.7M) has a higher market cap than TELIF($14.8M). RVXCF YTD gains are higher at: 97.924 vs. TELIF (4.256). TELIF has higher annual earnings (EBITDA): -1.32M vs. RVXCF (-10.54M). TELIF has more cash in the bank: 1.11M vs. RVXCF (153K). TELIF has less debt than RVXCF: TELIF (2.22M) vs RVXCF (17.6M). TELIF has higher revenues than RVXCF: TELIF (3.97M) vs RVXCF (0).
RVXCFTELIFRVXCF / TELIF
Capitalization22.7M14.8M153%
EBITDA-10.54M-1.32M802%
Gain YTD97.9244.2562,301%
P/E RatioN/A85.38-
Revenue03.97M-
Total Cash153K1.11M14%
Total Debt17.6M2.22M793%
FUNDAMENTALS RATINGS
RVXCF: Fundamental Ratings
RVXCF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RVXCFTELIF
RSI
ODDS (%)
Bearish Trend 4 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
68%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
74%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
56%
Advances
ODDS (%)
Bullish Trend 21 days ago
66%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 12 days ago
86%
Bearish Trend 11 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
RVXCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HAWPF10.62N/A
N/A
Haw Par Corp. Ltd.
CCOEY13.46N/A
N/A
Capcom Co. Ltd
FARYF0.25N/A
N/A
Far LTD
RBTK2.00N/A
N/A
Zhen Ding Resources Inc.
ENNPF17.54N/A
N/A
Enbridge Inc.

RVXCF and

Correlation & Price change

A.I.dvisor tells us that RVXCF and FULC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVXCF and FULC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVXCF
1D Price
Change %
RVXCF100%
N/A
FULC - RVXCF
25%
Poorly correlated
-2.31%
TELIF - RVXCF
23%
Poorly correlated
+0.70%
ATNM - RVXCF
22%
Poorly correlated
-4.55%
NGNE - RVXCF
21%
Poorly correlated
-4.10%
IDYA - RVXCF
20%
Poorly correlated
-1.13%
More

TELIF and

Correlation & Price change

A.I.dvisor tells us that TELIF and ATNM have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELIF and ATNM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELIF
1D Price
Change %
TELIF100%
+0.70%
ATNM - TELIF
28%
Poorly correlated
-4.55%
ELEV - TELIF
24%
Poorly correlated
N/A
RVXCF - TELIF
23%
Poorly correlated
N/A
TNFA - TELIF
23%
Poorly correlated
+13.53%
PMN - TELIF
20%
Poorly correlated
+11.35%
More